Brainstorm Recycles ALS Stem Cell Data to Boost Sagging Stock – TheStreet.com
TheStreet.com |
Brainstorm Recycles ALS Stem Cell Data to Boost Sagging Stock
TheStreet.com The company is announcing results of a small clinical trial of an experimental stem–cell therapy in patients with amyotrophic lateral sclerosis (ALS), the degenerative and fatal nerve disease also known as Lou Gehrig's disease. A more honest … BrainStorm Cell Therapeutics to Conduct Phase 2 Multi-Dose NurOwn® Trial in … Brainstorm Cell Therapeutics (BCLI) Announces Publication in JAMA Neurology … |
